Skip to main content
Premium Trial:

Request an Annual Quote

Roman Zubarev, David Simmons, Spyros Artavanis-Tsakonas, Christopher Buckley, Philip Cohen, Emilio Hirsch, Harren Jhoti, Bernhard Kuster, David Middlemiss, David Sabatini, Giulio Superti-Furga, Arthur Weiss

Premium
Roman Zubarev has joined the scientific advisory board of Sage-N Research, the company said this week. Zubarev is currently a professor at Uppsala University. He is collaborating with Sage-N on data analysis of electron transfer dissociation and pathway search engines, the company said.
 

 

Cellzome this week announced the creation of its scientific board, to be chaired by David Simmons, the company’s chief scientific officer. It also will include Spyros Artavanis-Tsakonas, Harvard Medical School; Christopher Buckley, University of Birmingham, UK; Philip Cohen, University of Dundee; Emilio Hirsch, University of Torino; Harren Jhoti, CEO of Astex Therapeutics; Bernhard Kuster, Technical University, Munich; David Middlemiss, XaviaPharm; David Sabatini, Whitehead Institute for Biomedical Research; Giulio Superti-Furga, Center of Molecular Medicine of the Austrian Academy of Sciences; Arthur Weiss, University of California.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.